The wrong picture
Compliance is misunderstood. Almost everywhere, almost always. It is treated as bureaucracy, as effort without return, as a tribute to an apparatus whose only function is to annoy. That picture is not just wrong. It is dangerous.
The right category is risk management. Whoever places a product on the market that fails the applicable safety and conformity requirements carries a risk that can materialise as a recall. As a fine. As a liability case. As criminal prosecution of management. As the loss of a listing at the largest retailer they have ever pitched.
The CE marking stands for a declaration: "I take responsibility for this product. I have verified it meets the requirements. I can prove it." A declaration that cannot be backed up is a declaration without basis. That is not a triviality — it is legally binding misinformation against the market.
What is at stake
A recall is not a bad day. It is a structural shock. Transport logistics, destruction, communication, legal advice, crisis management — all running in parallel under time pressure. What comes next is often worse: the listing loss at retailers who, in the meantime, have switched to other suppliers.
The criminal dimension is the hardest. German Geschäftsherrnhaftung makes whoever should have known about a risk and failed to act stand in the same place as whoever knew and failed to act. A toy maker whose product contains prohibited phthalates cannot defend with not knowing — if the test that would have shown it was never commissioned.
Proactive vs. reactive
There are two modes of dealing with compliance. Reactive: act when you must. When the authority comes, when a retailer demands evidence, when a recall threatens. Proactive: act before pressure builds. The cost difference is enormous.
Reactive compliance happens under time pressure. Time pressure drives price. Reactive compliance repairs damage rather than preventing it. It often arrives too late to avert listing loss or reputational harm. Proactive compliance is plannable, scalable, integrable into product-development budgets.
Excerpt from: Dr. Raphael Nagel — "Marktzulassung. How to bring your product to market in Switzerland and the EU — without recall, without liability, without detours." Tactical Management Press, 2026.